Critical Contrast: Research Frontiers (REFR) & ITUS (ITUS)

Research Frontiers (NASDAQ:REFR) and ITUS (NASDAQ:ITUS) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Earnings & Valuation

This table compares Research Frontiers and ITUS’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Research Frontiers $1.51 million 21.05 -$2.41 million ($0.10) -12.50
ITUS N/A N/A N/A N/A N/A

ITUS has lower revenue, but higher earnings than Research Frontiers.

Insider and Institutional Ownership

7.3% of Research Frontiers shares are owned by institutional investors. Comparatively, 4.7% of ITUS shares are owned by institutional investors. 9.5% of Research Frontiers shares are owned by company insiders. Comparatively, 23.6% of ITUS shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations for Research Frontiers and ITUS, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Research Frontiers 0 0 1 0 3.00
ITUS 0 0 0 0 N/A

Research Frontiers currently has a consensus target price of $3.00, suggesting a potential upside of 140.00%. Given Research Frontiers’ higher probable upside, research analysts clearly believe Research Frontiers is more favorable than ITUS.

Profitability

This table compares Research Frontiers and ITUS’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Research Frontiers -153.12% -82.15% -71.30%
ITUS N/A N/A N/A

About Research Frontiers

Research Frontiers Incorporated develops and markets technology and devices to control the flow of light in the United States. The company develops and licenses suspended particle device (SPD-Smart) light-control technology to companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, lamination services, and electronics to power end-products incorporating the film, as well as the end-products, such as windows, skylights, and sunroofs. Its SPD-Smart light-control technology is used in various product applications, including windows, sunshades, skylights, and interior partitions for homes and buildings; automotive windows, sunroofs, sun-visors, sunshades, rear-view mirrors, instrument panels, and navigation systems; aircraft windows; museum display panels and eyewear products; and flat panel displays for electronic products. The company serves aerospace, architectural, automotive, and marine industries. Research Frontiers Incorporated was founded in 1965 and is headquartered in Woodbury, New York.

About ITUS

ITUS Corporation develops, acquires, and licenses emerging technologies in the areas of biotechnology. The company develops Cchek, a platform for non-invasive blood tests for the early detection of various cancers, including breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar, and prostate cancer. It also develops immuno-therapy drugs for the treatment of cancer. The company was formerly known as CopyTele, Inc. and changed its name to ITUS Corporation in September 2014. ITUS Corporation was founded in 1982 and is based in San Jose, California.

Receive News & Ratings for Research Frontiers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Frontiers and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit